Charts

WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy (DPN). Hayashi and colleagues evaluated 167 patients with Type 1 or Type 2 diabetes. The reference standard for DPN was a gold standard nerve conduction study. The authors developed a predictive formula based on DPNCheck measurements, patient age

WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022. “We have been pleased by the positive response to Quell Fibromyalgia from providers taking care of patients with fibromyalgia during our strategic launch phase,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix. “This early adoption affirms the

NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Earlier today Echo Lake Capital sent a letter to the Board of Directors of Neurometrix, Inc. (NASDAQ:NURO). The letter listed the top ten reasons why the Board should immediately fire Shai Gozani, the company's longstanding Chairman and CEO. The reasons include (i) NURO's stock price has declined 99% since the IPO, (ii) while shareholders have suffered massive losses, Gozani has received over $10 million of compensation, (iii) Gozani was charged by the Federal Trade Commission for various wrongdoings at NURO, (iv) Gozani apparently personally paid $4 million to the FTC as part of a settlement, and (v) Gozani's decision to dilute shareholders by having NURO issue shares at prices significantly below net cash.

Stock trades significantly below its net cash per share. The board is arguably in breach of their fiduciary responsibility to protect shareholder value. Operating any capital raise at current price is grossly irresponsible and against shareholders ...

- Stock trades significantly below its net cash per share.

- Stock trades significantly below its net cash per share - Questions the Board's ability and/or desire to create shareholder value - Notes tremendous destruction of shareholder value under company's leadership - Sees no reason for company to remain ...

- Stock trades significantly below its net cash per share

NeuroMetrix ( NASDAQ:NURO ) Full Year 2023 Results Key Financial Results Revenue: US$5.90m (down 28% from FY 2022). Net...

NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript February 22, 2024 NeuroMetrix, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the NeuroMetrix Fourth Quarter 2023 Business and Financial Update. My name is Josh, and […]

Q4 2023 NeuroMetrix Inc Earnings Call

WOBURN, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2023. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medical devices. "Quell® Fibromyalgia growth accelerated in Q4 2023 reflecting the addition in Q3 2023 of two field business development managers and optimized clinical messaging. We also int

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on ...

WOBURN, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2023 fourth quarter and year end business and financial highlights before the opening of the market on February 22, 2024. The Company will host a conference call at 8:00 a.m., Eastern Time on February 22, 2024. For participants who wish to access the Q4 and year end 2023 Conference Call live via telephone and be able to ask questions, please register in advance here. Upon

WOBURN, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a commercial stage medical device company focused on reducing the impact of neurological disorders and pain syndromes through innovative non-invasive medical devices, today announced a process to review strategic options to promote growth of its Quell® neuromodulation and DPNCheck® neurodiagnostic businesses and to maximize shareholder value. The Company plans to consider a wide range of options, including changes

MIAMI, Jan. 09, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 66th Emerging Growth Conference on January 10 & 11, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp

WOBURN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on January 10, 2024. This live, interactive, online event will give shareholders and the investment community the opportunity to interact in real time with the Company’s Chairman and Chief Executive Officer, Dr. Shai N. Gozani. Dr. Gozani will present business highlights and recent developments, including the evolution of its Quell® neuromodula

WOBURN, Mass., Dec. 12, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) reported the recent presentation of data from a clinical trial of Quell wearable neuromodulation technology in patients with post-acute COVID-19 syndrome (PACS), commonly called Long COVID. The presentation was made at the National Science Foundation (NSF) funded Center to Stream Healthcare In Place (C2SHIP) annual meeting in Washington DC. The trial was conducted at the Baylor College of Medicine in collaboration

WOBURN, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of results from a NIH-funded clinical trial of Quell titled "Wireless transcutaneous electric nerve stimulation (TENS) for chronic chemotherapy-induced peripheral neuropathy (CIPN): a proof-of-concept randomized clinical trial." The paper has been electronically published in The Journal of Pain. The study was a phase 2, multi-site, double blinded, randomized, sham-controlled trial. A total of 142

WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm on November 21, 2023 (the “Effective Time”). The shares underlying the Company's outstanding options will also be adjusted accordingly. The reverse stock split is intended to increase the per share trading price of the Company's common stock to satisfy the $1.00 minimum bid price requirement for continued lis

Gainers Comera Life Sciences (NASDAQ:CMRA) stock increased by 11.6% to $0.28 during Friday's after-market session. The company's market ...

MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting

WOBURN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on Wednesday, November 1, 2023. This live, interactive, online event will give shareholders and the investment community the opportunity to interact in real time with the Company’s Chairman and Chief Executive Officer, Dr. Shai N. Gozani. Dr. Gozani will provide a brief update on business highlights and recent developments, including the evolut

NeuroMetrix, Inc. (NASDAQ:NURO) Q3 2023 Earnings Call Transcript October 27, 2023 Operator: Good morning, and welcome to NeuroMetrix Third Quarter 2023 Business and Financial Highlights Update. My name is Norma, and I’ll be your moderator on the call. On this call, the company may make statements which are not historical facts and are considered forward-looking […]

Q3 2023 NeuroMetrix Inc Earnings Call

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. GD Culture Group Limited (NASDAQ: GDC) ...

On Tuesday, 46 stocks hit new 52-week lows. Key Facts About Today's 52-WeekLows: The largest company by ...

Gainers Immunogen (NASDAQ:IMGN) shares rose 126.1% to $11.76 during Wednesday's regular session. As of 13:30 EST, Immunogen's stock is ...

Gainers Aptorum Gr (NASDAQ:APM) shares increased by 199.0% to $8.64 during Wednesday's pre-market session. The company's market cap ...

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth ...

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The ...

Gainers Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a ...

During Friday, 125 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Amazon.com ...

Thursday saw 177 companies set new 52-week lows. 52-Week Low Highlights: Tesla (NASDAQ:TSLA) was the largest firm by ...

Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of ...

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. DICE Therapeutics, Inc. ...

Gainers DICE Therapeutics (NASDAQ:DICE) shares rose 64.2% to $40.49 during Tuesday's regular session. As of 13:30 EST, DICE ...

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939. Laser Photonics Corporation (NASDAQ: LASE) rose ...

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its ...

Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's ...

Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average ...

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien ...

Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on ...

Gainers Theravance Biopharma (NASDAQ:TBPH) shares moved upwards by 29.8% to $11.2 during Wednesday's after-market session. At the ...

Gainers Precision BioSciences (NASDAQ:DTIL) shares moved upwards by 70.5% to $2.37 during Tuesday's after-market session. Precision ...

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 ...

Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 52.1% to $2.48 during Friday's regular session. The ...

Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413. TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped 25.6% to ...

On Thursday, shares of NeuroMetrix, Inc. (NASDAQ: NURO) experienced volatile short activity. After the activity, the stock price went up ...

Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 28.1% to $0.1550 in pre-market trading. Exicure said in Form4 filing a director ...

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA ...

Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's ...

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in NeuroMetrix and NURO stock are cheering an announcement that the FDA has approved the company to market its Quell device. The post Why Is NeuroMetrix (NURO) Stock Up 70% Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down ...

Gainers NeuroMetrix (NASDAQ:NURO) stock increased by 37.8% to $4.3 during Thursday's regular session. As of 13:30 ...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite adding 100 points on Thursday. The Dow traded down 0.68% ...

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo ...

U.S. stocks traded lower this morning, with the Dow Jones dipping more than 300 points on Thursday. Following the market opening ...

NeuroMetrix Inc (NASDAQ: NURO) shares are trading higher by 30.10% at $4.06 after the company announced the FDA has granted De Novo ...

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga ...

Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at ...

Biotech stocks extended their loses in the week endingApril 22. The sector took cues from the broader market, which reacted to the ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Traders ready for another busy day of investing will want to know all about the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”